Tena Proskin Barrier

Dosage for Dimethicone varies significantly based on the intended clinical use. For its role in calculi management or as a nutritional adjunct:

• Standard Oral Range: 40 mg to 125 mg taken four times daily, depending on the severity of the condition.
• Maximum Dose: Typically should not exceed 500 mg in a 24-hour period unless directed by a specialist.

Dimethicone is generally considered safe for pediatric use when administered under medical supervision.

• Infants/Children: Dosing is often weight-based or provided in standardized drops (e.g., 20-40 mg per dose).
• Note: Always consult a pediatrician before administering Dimethicone to children under the age of 2.

Renal Impairment

No specific dose adjustments are typically required for patients with kidney disease due to the lack of systemic absorption. However, if used as a calculi dissolution agent, underlying renal function must be monitored.

Hepatic Impairment

No dosage adjustments are necessary for patients with liver impairment.

Elderly Patients

Clinical studies have not identified significant differences in response between elderly and younger patients. Dose selection should be cautious, starting at the lower end of the dosing range.

• Administration: If taking oral liquids, shake the container well before use. Tablets should be chewed thoroughly or swallowed as directed on the label.
• Timing: For gastrointestinal or dissolution purposes, it is often best taken after meals and at bedtime.
• Storage: Store at room temperature (20°C to 25°C) away from moisture and heat. Do not freeze liquid formulations.

If a dose is missed, take it as soon as you remember. If it is almost time for the next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.

Symptoms of overdose are rare but may include severe diarrhea or abdominal cramping. In case of accidental ingestion of large quantities, contact a poison control center or seek emergency medical attention immediately.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

Dimethicone is generally well-tolerated. Common effects may include:

• Mild Nausea: A feeling of queasiness shortly after administration.
• Diarrhea: Loose stools, particularly if the dose is high.
• Abdominal Bloating: A sensation of fullness or gas.

• Constipation: Difficulty passing stools.
• Regurgitation: A sour or bitter taste in the mouth following oral liquid administration.
• Contact Dermatitis: If used topically, mild redness or itching at the application site.

• Severe Allergic Reaction: Characterized by hives or localized swelling.
• Electrolyte Imbalance: Rare, but possible if used extensively as an acidifying agent.

> Warning: Stop taking Dimethicone and call your doctor immediately if you experience any of these.

• Anaphylaxis: Symptoms include difficulty breathing, swelling of the face, lips, or tongue, and severe dizziness.
• Severe Abdominal Pain: Sharp, persistent pain that may indicate a more serious underlying gastrointestinal issue.
• Persistent Vomiting: Inability to keep fluids down, leading to dehydration.

Prolonged use of Dimethicone is generally considered safe; however, chronic use as a calculi dissolution agent requires periodic monitoring of mineral levels to ensure that the acidifying activity does not adversely affect bone density or systemic pH balance.

No FDA black box warnings have been issued for Dimethicone as of 2024. It is considered a low-risk medication when used according to standard clinical guidelines.

Report any unusual symptoms to your healthcare provider.

Patients should be aware that while Dimethicone is often available over-the-counter, its use in treating calculi or as an anticoagulant adjunct must be supervised by a healthcare professional. Ensure you are using the correct formulation for your specific medical need.

No FDA black box warnings for Dimethicone.

• Allergic Reactions: Patients with a known hypersensitivity to silicone or any component of the formulation should avoid use. Anaphylaxis, though rare, is a medical emergency.
• Gastrointestinal Obstruction: If you have a known or suspected bowel obstruction, consult a doctor before use, as the medication may alter gastric motility.
• Aspiration Risk: In elderly or debilitated patients, care should be taken with liquid formulations to avoid accidental inhalation into the lungs.

For patients using Dimethicone for calculi dissolution:

• Urinary pH: Regular monitoring to ensure the acidifying effect is within the therapeutic range.
• Renal Ultrasound: To track the progress of stone dissolution.
• Electrolyte Panels: Occasional blood tests to check calcium and phosphate levels.

Dimethicone does not typically cause drowsiness or cognitive impairment. It is generally safe to drive or operate machinery while taking this medication.

There are no known direct interactions between alcohol and Dimethicone. However, alcohol can irritate the gastrointestinal tract and may exacerbate some side effects like nausea or diarrhea.

Dimethicone can usually be stopped abruptly without withdrawal symptoms. However, if being used for a chronic condition, symptoms may return upon discontinuation. Consult your provider before stopping a prescribed regimen.

> Important: Discuss all your medical conditions with your healthcare provider before starting Dimethicone.

There are no absolute drug-drug contraindications that require complete avoidance of Dimethicone. However, its physical properties may interfere with the absorption of other medications.

• Oral Medications: Dimethicone can coat the stomach lining or bind to other drugs, potentially reducing the absorption of medications like Digoxin, Warfarin, or Levothyroxine. Space these medications at least 2 hours apart from Dimethicone.
• Quinolone Antibiotics: Chelating activity may reduce the efficacy of antibiotics like Ciprofloxacin or Levofloxacin.

• Antacids: Using other antacids simultaneously may neutralize the acidifying activity of Dimethicone in calculi dissolution protocols.
• Sucralfate: May have additive effects on the gastric mucosa, potentially leading to constipation.

• High-Fat Meals: May slightly delay the transit time of Dimethicone through the gut but does not significantly impact its efficacy.
• Dairy Products: Large amounts of calcium-rich foods might interfere with the calcium-chelating activity of the drug.

• Calcium Supplements: May directly compete with the medication's chelating mechanism.
• St. John's Wort: No known metabolic interaction, but general caution is advised with polypharmacy.

Dimethicone is not known to interfere with standard blood or urine laboratory tests, though its presence in the stool may occasionally interfere with certain fecal occult blood tests depending on the methodology used.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

• Hypersensitivity: Known severe allergy to Dimethicone or silicone-based products. Exposure could lead to life-threatening anaphylaxis.
• Intestinal Perforation: Use is strictly prohibited in patients with suspected or confirmed perforation of the gastrointestinal tract.

• Severe Constipation: May be exacerbated by certain Dimethicone formulations.
• Chronic Kidney Disease (Stage 4 or 5): Requires careful monitoring if the drug is being used for mineral dissolution due to the risk of altering systemic electrolyte balance.

Patients who react to other siloxanes or silicone-based medical adhesives may have an increased risk of reaction to Dimethicone.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Dimethicone.

FDA Pregnancy Category: Not formally assigned (Generally recognized as safe). Dimethicone is not systemically absorbed in significant amounts, making it unlikely to pose a risk to the developing fetus. However, it should only be used during pregnancy if clearly needed and under medical advice.

Dimethicone is not expected to pass into breast milk due to its large molecular size and lack of systemic absorption. It is generally considered compatible with breastfeeding. No adverse effects have been reported in nursing infants.

Approved for use in infants and children for gas relief and as a protective agent. For calculi dissolution, its use in children is considered off-label and must be strictly managed by a pediatric specialist.

Elderly patients may be more prone to constipation or aspiration of liquid forms. No specific dosage reductions are required, but monitoring for gastrointestinal motility is recommended.

No dose adjustment is necessary for patients with mild to moderate renal impairment. In end-stage renal disease, monitor for potential changes in mineral metabolism if the drug is used long-term.

No dosage adjustment is required for patients with any degree of hepatic impairment, as the liver is not involved in the drug's clearance.

> Important: Special populations require individualized medical assessment.

Dimethicone acts as a surfactant and a chelating agent. In the context of Calculi Dissolution, it reduces the surface tension of gas bubbles and mineral deposits. Its Acidifying Activity helps lower the local pH, which increases the solubility of calcium-based stones. Furthermore, its Calcium Chelating Activity allows it to bind to free calcium ions, preventing the crystallization of stone-forming salts.

The effects of Dimethicone are primarily local and physical. The onset of action for gastrointestinal gas relief is typically within 30 to 60 minutes. For calculi dissolution, the effect is cumulative and may take weeks of consistent dosing to show measurable results on imaging.

| Parameter | Value |

|---|---|

| Bioavailability | < 1% (Oral) |

| Protein Binding | Negligible |

| Half-life | N/A (Not systemically absorbed) |

| Tmax | 1-2 hours (Local peak) |

| Metabolism | None |

| Excretion | Fecal (approx. 99%+) |

• Molecular Formula: (C2H6OSi)n
• Molecular Weight: Varies (Polymer)
• Solubility: Insoluble in water and ethanol; soluble in chlorinated hydrocarbons.
• Structure: A mixture of fully methylated linear siloxane polymers containing repeating units of the formula [–(CH3)2SiO–]n.

Dimethicone is classified as a Calculi Dissolution Agent [EPC] and a Skin Protectant. It belongs to the broader category of organosilicon compounds.